These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6144556)

  • 1. Effects of spasmolytics on K+-induced contraction of rat intestine in vivo.
    Subissi A; Brunori P; Bachi M
    Eur J Pharmacol; 1983 Dec; 96(3-4):295-301. PubMed ID: 6144556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vivo procedure for estimating spasmolytic activity in the rat by measuring smooth muscle contractions to topically applied acetylcholine.
    Maggi CA; Meli A
    J Pharmacol Methods; 1982 Aug; 8(1):39-46. PubMed ID: 7121016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of nifedipine and verapamil on high K+ induced contractions of the rat intestinal tract in vivo.
    Maggi CA; Grimaldi G; Meli A
    Jpn J Pharmacol; 1983 Apr; 33(2):335-41. PubMed ID: 6887644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of smooth muscle relaxation by rociverine.
    D'Agostino G; Zonta F; Santagostino Barbone MG; Grana E; Brunori P; Subissi A
    Arzneimittelforschung; 1984; 34(5):584-9. PubMed ID: 6540576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octylonium bromide: a smooth muscle relaxant which interferes with calcium ions mobilization.
    Maggi CA; Manzini S; Meli A
    Arch Int Pharmacodyn Ther; 1983 Aug; 264(2):305-23. PubMed ID: 6639222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of potential selectivity of antispasmodics for the various sections of the gastrointestinal tract of the rat as a guideline for their clinical use.
    Maggi CA; Meli A
    Arch Int Pharmacodyn Ther; 1983 Apr; 262(2):221-31. PubMed ID: 6135399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rociverine and other spasmolytic agents on caerulein-induced delay in gastric emptying in the conscious rat.
    Subissi A; Guelfi M
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):130-7. PubMed ID: 7114969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional selectivity of calcium blockers at intestinal level.
    Maggi CA; Manzini S; Meli A
    Arch Int Pharmacodyn Ther; 1985 Aug; 276(2):202-21. PubMed ID: 2413814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rociverine compared with other spasmolytics for cardiovascular effects.
    Guelfi M; Schiantarelli P; Subissi A
    Farmaco Prat; 1981 Aug; 36(8):374-82. PubMed ID: 7274417
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of temperature and spasmolytic agents on the rate of relaxation of intestinal smooth muscle.
    Tomiyama A; Hurwitz L
    Proc West Pharmacol Soc; 1975; 18():87-92. PubMed ID: 1178714
    [No Abstract]   [Full Text] [Related]  

  • 11. [Spasmolytics and analgesics in a model of ureteral hyperactivity in dogs].
    Salinas Casado J
    Arch Esp Urol; 1982; 35(1):1-4. PubMed ID: 7103565
    [No Abstract]   [Full Text] [Related]  

  • 12. Rociverine citrate: a new spasmolytic agent, potentially useful in the treatment of urinary bladder hyperreflexia.
    Subissi A; Maggi CA; Meli A
    Jpn J Pharmacol; 1986 Oct; 42(2):153-7. PubMed ID: 3540391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antispasmodic drugs on colonic motility. Part I: Laboratory study of the dog.
    Sasaki D; Kido A; Yoshida Y
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):333-7. PubMed ID: 6147311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of trimebutine maleate on modulating intestinal hypercontractility in a mouse model of postinfectious irritable bowel syndrome.
    Long Y; Liu Y; Tong J; Qian W; Hou X
    Eur J Pharmacol; 2010 Jun; 636(1-3):159-65. PubMed ID: 20371236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experments on the mechanism of action of vascular spasmolytic agents. I. Effect nitroprusside sodium, nitroglycerine, prenylamine and verapamil on the arrested potassium contracture of isolated coronary arteries].
    Fermum R; Klinner U; Meisel P
    Acta Biol Med Ger; 1976; 35(10):1347-58. PubMed ID: 828374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of N-butylscopolammonium bromide on equine ileal smooth muscle activity in an ex vivo model.
    Hart KA; Sherlock CE; Davern AJ; Lewis TH; Robertson TP
    Equine Vet J; 2015 Jul; 47(4):450-5. PubMed ID: 24779926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the anticholinergic drug prifinium bromide on urinary bladder contractions in rat in vivo and in guinea-pig in vitro.
    Terai T; Deguchi Y; Ohtsuka M; Kumada S
    Arzneimittelforschung; 1991 Apr; 41(4):417-20. PubMed ID: 1677577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rociverine, a new antispasmodic agent with balanced neurotropic and myotropic activity.
    Toson G; Schiantarelli P; Murmann W
    Arzneimittelforschung; 1978; 28(7):1130-42. PubMed ID: 582702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome.
    Evangelista S
    Curr Pharm Des; 2004; 10(28):3561-8. PubMed ID: 15579053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cimetropium: characterization of antimuscarinic and spasmolytic properties.
    Schiavone A; Schiavi GB; De Conti L; Micheletti R; Sagrada A; Hammer R; Giachetti A
    Arzneimittelforschung; 1985; 35(5):796-9. PubMed ID: 4026901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.